Able Laboratories, Inc. Sees FDA Withdraw Approval of Ten Abbreviated New Drug Applications

Summary

Able Laboratories, Inc. has had the FDA withdraw approval of ten abbreviated new drug applications due to a class II recall of the products covered by these applications, following a request from the company.